ArticleJournal of endocrinological investigation2018

Metabolic benefits of 1-(3-(4-(o-tolyl)piperazin-1-yl)propyl)pyrrolidin-2-one: a non-selective α-adrenoceptor antagonist.

Magdalena Kotańska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.